Torii Pharmaceutical Co Ltd
TSE:4551

Watchlist Manager
Torii Pharmaceutical Co Ltd Logo
Torii Pharmaceutical Co Ltd
TSE:4551
Watchlist
Price: 4 435 JPY 0.68% Market Closed
Market Cap: 127.7B JPY
Have any thoughts about
Torii Pharmaceutical Co Ltd?
Write Note

Torii Pharmaceutical Co Ltd
Other Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Torii Pharmaceutical Co Ltd
Other Current Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Torii Pharmaceutical Co Ltd
TSE:4551
Other Current Liabilities
ÂĄ3.8B
CAGR 3-Years
-4%
CAGR 5-Years
-29%
CAGR 10-Years
1%
Takeda Pharmaceutical Co Ltd
TSE:4502
Other Current Liabilities
ÂĄ1.3T
CAGR 3-Years
0%
CAGR 5-Years
3%
CAGR 10-Years
11%
Daiichi Sankyo Co Ltd
TSE:4568
Other Current Liabilities
ÂĄ140.7B
CAGR 3-Years
41%
CAGR 5-Years
25%
CAGR 10-Years
8%
Otsuka Holdings Co Ltd
TSE:4578
Other Current Liabilities
ÂĄ373.1B
CAGR 3-Years
15%
CAGR 5-Years
13%
CAGR 10-Years
6%
Chugai Pharmaceutical Co Ltd
TSE:4519
Other Current Liabilities
ÂĄ150.3B
CAGR 3-Years
12%
CAGR 5-Years
15%
CAGR 10-Years
14%
Astellas Pharma Inc
TSE:4503
Other Current Liabilities
ÂĄ624.9B
CAGR 3-Years
23%
CAGR 5-Years
18%
CAGR 10-Years
15%
No Stocks Found

Torii Pharmaceutical Co Ltd
Glance View

Market Cap
124.7B JPY
Industry
Pharmaceuticals

Torii Pharmaceutical Co., Ltd. engages in the manufacturing and marketing of pharmaceutical products. The company is headquartered in Chuo-Ku, Tokyo-To and currently employs 560 full-time employees. The company went IPO on 2013-10-01. The Company’s main product categories include oral pruritus improving agents, proteolytic enzyme inhibitors, hyperkalemia improving agents, topical adrenocortical hormones, allergen immunotherapy for cedar pollinosis, allergen immunotherapy for mite allergy, active viable bacterial preparations, uterine contraction inhibitors in premature birth and others. The Company’s main products include Remitch, Riona tablets, Keixalate, Yulinome tablets, Antebate, Locoid, Zefnate, Sida Torengi pollen sublingual solution, Miticure mite sublingual tablet, Biosley, Magcent and others.

Intrinsic Value
3 292.36 JPY
Overvaluation 26%
Intrinsic Value
Price

See Also

What is Torii Pharmaceutical Co Ltd's Other Current Liabilities?
Other Current Liabilities
3.8B JPY

Based on the financial report for Sep 30, 2024, Torii Pharmaceutical Co Ltd's Other Current Liabilities amounts to 3.8B JPY.

What is Torii Pharmaceutical Co Ltd's Other Current Liabilities growth rate?
Other Current Liabilities CAGR 10Y
1%

Over the last year, the Other Current Liabilities growth was -19%. The average annual Other Current Liabilities growth rates for Torii Pharmaceutical Co Ltd have been -4% over the past three years , -29% over the past five years , and 1% over the past ten years .

Back to Top